… A recent study from Archives of Neurology suggests that those with … recent studies have found that the risk for melanoma is not from taking the dopaminergic drugs but, instead, from having Parkinson’s. While the jury is still out on what …

… Yesterday nearly 40 world-renowned experts from academia, industry, government and non-profits met at … in GBA mutation carriers for the first time . Today's workshop, co-led by The Silverstein Foundation for Parkinson's … strategy: gathering valuable data and biological samples from mutation carriers, funding investigations to draw lines …

… For a generation not yet born that might be alleviated from the disease that we struggle with today, what you do … training sessions and educational panels. Attendees heard from legislative experts, scientists and health care … patients and care partners. You can view these panels from your own home by visiting The Michael J. Fox Foundation …

… Earlier this month, scientists from The Michael J. Fox Foundation (MJFF) traveled to Italy … who do not have LRRK2 mutations. Mark Cookson, PhD, from the Laboratory of Neurogenetics at the NIH discussed … meeting presentations received direct or indirect support from MJFF. And we are committed to continuing this work by …

… conditions, and others. The Parkinson’s scent seems to come from a waxy, oily substance (sebum) that protects and … using alcohol- and perfume-free body wipes to remove sebum from the chest, back and other skin areas that make a lot of … with symptoms like this. You can connect with and learn from others through MJFF’s Buddy Network. Learn more about …

… suggests that AMI has pharmacological properties distinct from other antidepressant medications that makes it more … venlafaxine, for effects on protecting dopamine nerve cells from degeneration in a toxin model of parkinsonism. No …